Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

This program funds biomedical, behavioral, and social science research on the causes and mechanisms of neuropsychiatric symptoms in people with Alzheimer’s disease or related dementias, including mechanistic clinical trials. It is open to a wide range of U.S. and non-U.S. organizations, including nonprofits, universities, governments, small businesses, and foreign organizations, and foreign components of U.S. organizations are allowed. The award is a grant for a two-year project period, with no more than $275,000 in direct costs total and no more than $200,000 in any single year. Cost sharing is not required.

✳ AI-generated summary — verify against the announcement

• Health
• Research & Discovery
• Older Adults & Family Caregivers
• Aging, Dementia & Caregiving
• Biomedical & Disease Research
• Mental & Behavioral Health

• ✓ City or township governments
• ✓ County governments
• ✓ For-profit organizations other than small businesses
• ✓ Independent school districts
• ✓ Native American tribal governments (Federally recognized)
• ✓ Native American tribal organizations (other than Federally recognized)
• ✓ Nonprofits with 501(c)(3) status (other than higher education)
• ✓ Nonprofits without 501(c)(3) status (other than higher education)
• ✓ Others
• ✓ Private institutions of higher education
• ✓ Public and State controlled institutions of higher education
• ✓ Public housing authorities / Indian housing authorities
• ✓ Small businesses
• ✓ Special district governments
• ✓ State governments